PELLEI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 387
EU - Europa 230
AS - Asia 87
AF - Africa 22
SA - Sud America 14
Totale 740
Nazione #
US - Stati Uniti d'America 387
SE - Svezia 51
IT - Italia 47
UA - Ucraina 34
SG - Singapore 31
CN - Cina 27
DE - Germania 21
IE - Irlanda 21
RU - Federazione Russa 19
CI - Costa d'Avorio 18
DK - Danimarca 13
TR - Turchia 13
BR - Brasile 12
FI - Finlandia 12
KR - Corea 7
HK - Hong Kong 5
NL - Olanda 4
FR - Francia 3
GB - Regno Unito 3
MA - Marocco 3
IN - India 2
VN - Vietnam 2
AR - Argentina 1
CZ - Repubblica Ceca 1
EG - Egitto 1
RS - Serbia 1
VE - Venezuela 1
Totale 740
Città #
Chandler 58
Jacksonville 34
New York 30
Boardman 26
Wilmington 24
Ashburn 23
Dublin 21
Fairfield 21
Abidjan 18
Woodbridge 15
Des Moines 13
Singapore 13
Seattle 12
Cambridge 11
Lawrence 8
Princeton 8
San Mateo 8
Turin 8
Houston 6
Moscow 6
Beijing 5
Centro 5
Hong Kong 5
Rome 5
Munich 4
Ann Arbor 3
Fermignano 3
San Diego 3
Turku 3
Wuxi 3
Ancona 2
Hanoi 2
Helsinki 2
Isola della Scala 2
Jinan 2
London 2
Los Angeles 2
Marche 2
Nanjing 2
Pune 2
Acarigua 1
Alexandria 1
Amsterdam 1
Aparecida de Goiânia 1
Atlanta 1
Bauru 1
Belo Horizonte 1
Brasília 1
Changsha 1
Chicago 1
Dalian 1
Dallas 1
Denver 1
Erechim 1
Frankfurt am Main 1
Gramado 1
Guangzhou 1
Hounslow 1
Itapetininga 1
Jaboatão dos Guararapes 1
Jiaxing 1
Jinhua 1
Joinville 1
Macerata 1
Milan 1
Modena 1
Newark 1
Norwalk 1
Nuremberg 1
Olomouc 1
Puerto Madryn 1
Rio Branco 1
Rio Grande 1
San Francisco 1
San Severino Marche 1
Santa Clara 1
Santa Maria a Monte 1
Shenzhen 1
São Paulo 1
The Dalles 1
Washington 1
Wuhan 1
Totale 464
Nome #
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 115
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 100
Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target 98
HER family receptor expression and prognosis in pancreatic cancer 91
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 89
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 77
Trattamento del carcinoma del pancreas. Attualità e prospettive 75
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 73
Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients 42
Totale 760
Categoria #
all - tutte 4.565
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.565


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 0 0 0 0 0 0 0 0 0 0 2 10
2020/2021132 7 12 15 3 8 10 10 11 17 12 17 10
2021/202263 2 9 3 5 0 6 1 4 4 10 5 14
2022/2023181 11 26 9 11 14 32 0 6 45 4 21 2
2023/2024117 18 3 6 15 13 40 0 2 0 2 1 17
2024/2025151 38 13 5 3 14 11 15 4 24 8 16 0
Totale 760